BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/28/2016 3:07:00 PM | Browse: 690 | Download: 1794
Publication Name World Journal of Clinical Infectious Diseases
Manuscript ID 25846
Country United States
ISSN 2220-3176 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Challenges in management of recurrent and refractory Clostridium difficile infection
Manuscript Source Invited Manuscript
All Author List Anne M Meehan, Raseen Tariq and Sahil Khanna
Funding Agency and Grant Number
Corresponding Author Sahil Khanna, MBBS, MS, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. khanna.sahil@mayo.edu
Key Words Clostridium difficile infection; Epidemiology; Outcomes; Treatment; Fecal microbiota transplantation
Core Tip Recurrent Clostridium difficile infection (RCDI) is common and can be difficult to treat. Clostridia spores transmit disease. They are ubiquitous and hard to eradicate. The composition of the gut microbiome plays an essential yet poorly understood role in main-taining overall health, and in protecting against Clostri-dium difficile (C. difficile) infection. Antibiotic induced dysbiosis of the microbiome is a key contributor to RCDI. Here we review how C. difficile spores and altera-tions in the microbiome contribute to RCDI.
Publish Date 2016-08-25 09:10
Citation Meehan AM, Tariq R, Khanna S. Challenges in management of recurrent and refractory Clostridium difficile infection. World J Clin Infect Dis 2016; 6(3): 28-36
URL http://www.wjgnet.com/2220-3176/full/v6/i3/28.htm
DOI http://dx.doi.org/10.5495/wjcid.v6.i3.28
Full Article (PDF) WJCID-6-28.pdf
Full Article (Word) WJCID-6-28.doc